معرفی
Benoît Chassaing is a French researcher and Associate Professor specializing in microbiota and chronic inflammatory diseases. He currently serves as Director of Research and Head of the Microbiome-Host Interactions group at the Institut Pasteur in Paris, France, and holds a partnership contract with IHU INFINY (University Hospital Institute on inflammatory bowel disease in Nancy). His work focuses on the impact of diet, food additives, and emulsifiers on gut microbiota biodiversity and its link to conditions like Crohn's disease, diabetes, and obesity. He advocates for personalized medicine approaches to restore microbiota diversity disrupted by industrialized diets.
Education:
- 2019: Accreditation to supervise research, Université Paris Descartes
- 2011: PhD in Genetic and Molecular Physiology, Université d'Auvergne
- 2008: Master of Science in Genetics and Physiology, Université d'Auvergne
Research Interests: Benoît’s research bridges microbiology, immunology, and nutrition, emphasizing translational medicine. His team investigates how emulsifiers (e.g., E471) reduce microbial diversity, promote pathogenic bacteria, and contribute to chronic diseases. Collaborative clinical trials demonstrated that eliminating additives improves remission rates in Crohn’s patients. He also explores probiotics, dietary fibers, and fecal transplants as therapeutic strategies.
Awards:
- ERC Starting Grant (2017)
- ERC Consolidator Grant (recent)
Labs & Collaborations: Leading the Microbiome-Host Interactions group at Institut Pasteur, he collaborates globally on microbiome biobanks to preserve biodiversity. His work aligns with Institut Pasteur’s priorities on gut health and translational research.
